Nevro Corp. - stock earnings
NVRO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -9.0 million USD | 116.2 million USD |
| 2023Q3 | -23.5 million USD | 103.9 million USD |
| 2023Q2 | -24.7 million USD | 108.8 million USD |
| 2023Q1 | -35.0 million USD | 96.3 million USD |
| 2022Q4 | -19.2 million USD | 113.8 million USD |
| 2022Q3 | 81.5 million USD | 100.5 million USD |
| 2022Q2 | -25.0 million USD | 104.2 million USD |
| 2022Q1 | -34.3 million USD | 87.8 million USD |
| 2021Q4 | -30.1 million USD | 102.8 million USD |
| 2021Q3 | -50.1 million USD | 93.2 million USD |
| 2021Q2 | -21.6 million USD | 102.3 million USD |
| 2021Q1 | -29.6 million USD | 88.6 million USD |
| 2020Q4 | -7.1 million USD | 109.7 million USD |
| 2020Q3 | -10.0 million USD | 108.5 million USD |
| 2020Q2 | -41.1 million USD | 56.4 million USD |
| 2020Q1 | -24.9 million USD | 87.5 million USD |
| 2019Q4 | -13.7 million USD | 114.4 million USD |
| 2019Q3 | -17.8 million USD | 100.2 million USD |
| 2019Q2 | -28.0 million USD | 93.6 million USD |
| 2019Q1 | -44.1 million USD | 82.1 million USD |
| 2018Q4 | -9.6 million USD | 107.9 million USD |
| 2018Q3 | -11.3 million USD | 95.6 million USD |
| 2018Q2 | -10.6 million USD | 96.1 million USD |
| 2018Q1 | -17.7 million USD | 87.6 million USD |
| 2017Q4 | -4.3 million USD | 98.0 million USD |
| 2017Q3 | -6.2 million USD | 82.3 million USD |
| 2017Q2 | -11.6 million USD | 78.0 million USD |
| 2017Q1 | -14.5 million USD | 68.4 million USD |
| 2016Q4 | -9.8 million USD | 70.5 million USD |
| 2016Q3 | -3.9 million USD | 60.9 million USD |
| 2016Q2 | -8.8 million USD | 55.4 million USD |
| 2016Q1 | -9.3 million USD | 41.7 million USD |
| 2015Q4 | -14.2 million USD | 33.1 million USD |
| 2015Q3 | -19.5 million USD | 15.4 million USD |
| 2015Q2 | -19.7 million USD | 11.4 million USD |
| 2015Q1 | -14.1 million USD | 9.7 million USD |
| 2014Q4 | -8.3 million USD | 9.7 million USD |
| 2014Q3 | -7.9 million USD | 8.7 million USD |
| 2014Q2 | -7.4 million USD | 7.5 million USD |
| 2014Q1 | -7.1 million USD | 6.7 million USD |
| 2013Q4 | -6.7 million USD | 6.2 million USD |
| 2013Q3 | -5.0 million USD | 6.2 million USD |
| 2013Q2 | ? USD | 11.1 million USD |
| 2012Q4 | ? USD | 18.2 million USD |
NVRO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -92.2 million USD | 425.2 million USD |
| 2022 | 3.0 million USD | 406.4 million USD |
| 2021 | -131.4 million USD | 386.9 million USD |
| 2020 | -83.1 million USD | 362.0 million USD |
| 2019 | -103.7 million USD | 390.3 million USD |
| 2018 | -49.2 million USD | 387.3 million USD |
| 2017 | -36.7 million USD | 326.7 million USD |
| 2016 | -31.8 million USD | 228.5 million USD |
| 2015 | -67.4 million USD | 69.6 million USD |
| 2014 | -30.7 million USD | 32.6 million USD |
| 2013 | -26.0 million USD | 23.5 million USD |
| 2012 | -19.0 million USD | 18.2 million USD |
NVRO
Price: $11.32
52 week price:
Earnings Per Share: -2.56 USD
P/E Ratio: -6.02
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 496000
Ebitda: -2.7 millionMarket Capitalization: 482.3 million